AMBER KOSTIAL: Open Payments
NPI 1760772693 · BELLINGHAM, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 6 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $103 |
| ACADIA Pharmaceuticals Inc | 2 | $51 |
Products named: INGREZZA, NUPLAZID.
Industry payments across WA — which companies pay providers there.
